Tests on tracheal swab samples established that the virus was a new genetic reassortment avian-origin H10N8 virus (JX346). Whole genome sequencing indicated that all the genes of the virus were of avian origin, with six internal ...
Feb 4, 2014
0
0
December 3, 2013) St. Jude Children's Research Hospital scientists have evidence that descendants of the H2N2 avian influenza A virus that killed millions worldwide in the 1950s still pose a threat to human health, particularly ...
Dec 3, 2013
0
0
When a new strain of bird flu surfaced in China in February, it was an ominous echo of the 1997 outbreak in Hong Kong. People connected to poultry markets were again falling ill as scientists raced to decipher a novel strain: ...
Aug 19, 2013
0
0
(Medical Xpress)—A new study in the US suggests that boosting a certain group of antibodies could help to create a universal vaccine for influenza.
Scientists proposed developing a more potent strain of the deadly H7N9 bird flu on Wednesday to examine how mutant forms might spread among humans, a topic that has stoked global alarm in the past.
Aug 7, 2013
1
0
Scientists have for the first time traced a novel virus that infected two men from northwestern Missouri in 2009 to populations of ticks in the region, providing confirmation that lone star ticks are carrying the recently ...
Jul 22, 2013
2
0
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine concept, which ...
May 22, 2013
0
0
A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference ...
May 20, 2013
0
0
Researchers at Weill Cornell Medical College have successfully tested their novel anti-cocaine vaccine in primates, bringing them closer to launching human clinical trials. Their study, published online by the journal Neuropsychopharmacology, ...
May 10, 2013
0
0
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of ...
Apr 26, 2013
0
0
